Connect Sign In
3003751
JAK2 (V617F) Mutation by ddPCR, Quantitative
JAK2V617FQ
Ordering Recommendation
Aids in the workup of suspected myeloproliferative neoplasms. Use to detect the JAK2 V617F mutation in peripheral blood or bone marrow.
New York DOH Approval Status
This test is New York state approved.
Specimen Required
Patient Preparation
Collect
Whole blood or bone marrow in lavender (EDTA). Also acceptable: Whole blood in green (sodium heparin).
Specimen Preparation
Whole Blood: Do not freeze. Transport 5 mL whole blood. (Min: 1 mL)
Bone Marrow: Do not freeze. Transport 3 mL bone marrow. (Min: 1 mL)
Storage/Transport Temperature
Refrigerated.
Unacceptable Conditions
Plasma, serum, FFPE tissue blocks/slides, or fresh or frozen tissue. Specimens collected in anticoagulants other than EDTA or sodium heparin. Clotted or grossly hemolyzed specimens.
Remarks
Stability
Refrigerated: 7 days; Frozen: Unacceptable
Methodology
Droplet Digital PCR (ddPCR)
Performed
Varies
Reported
2-9 days
Reference Interval
Interpretive Data
Refer to report.
Compliance Category
Laboratory Developed Test (LDT)
Note
Hotline History
N/A
CPT Codes
81270
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 3003752 | JAK2 QNT, Source | 31208-2 |
| 3003753 | JAK2 V617F Percent Mutated Alleles | 53761-3 |
| 3003754 | JAK2 V617F Mutation by PCR | 43399-5 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- BCR-ABL1 negative testing
- Classic BCR-ABL1-negative testing
- MPN JAK2
- mutant JAK2 V617F allelic burden
JAK2 (V617F) Mutation by ddPCR, Quantitative
